Lipid profile and nutritional status of a pediatric population with sickle cell anemia: differences between gender and association with severity markers




Sickle cell anemia; Dyslipidemia; Apolipoprotein A1; Nutrition status; Vitamin A; Vitamin D.


Objective: To investigate the associations between nutritional status and lipid profile with biomarkers of hemolysis and inflammation in sickle cell anemia, in addition to considering gender differences. Methods: This cross-sectional study analyzed nutritional, and biochemical data of pediatric patients carrying sickle cell anemia. Results: Vitamin A, apolipoprotein B, total cholesterol, low-density lipoprotein, and non-high-density lipoprotein cholesterol were lower in boys. Hemoglobin was significantly lower, and the white blood cells and lactate dehydrogenase were higher in boys. Body mass index, vitamin A, and triglycerides were associated with hemoglobin levels, while apolipoprotein A-I was associated with white blood cells and total bilirubin. Additionally, body mass index and vitamin A were associated with lactate dehydrogenase. Vitamin A showed significant predictive power in hemoglobin alteration and lactate dehydrogenase, while apolipoprotein A-I was able to predict high white blood cells values and total bilirubin. Conclusion: This study found in a pediatric population with sickle cell anemia that body mass index, vitamin A, triglycerides, and apolipoprotein A-I were associated with biomarkers of hemolysis and inflammation. Boys exhibited the greater nutritional deficit and severity of the disease.

Author Biographies

Leandro Roberto de Macedo, Universidade Federal de Juiz de Fora

Andreza da Silva Brito Rocha, Universidade Federal de Juiz de Fora



Maria Anete Santana Valente, Universidade Federal de Juiz de Fora



Jacqueline Isaura Alvarez-Leite, Universidade Federal de Minas Gerais



Cibele  Velloso-Rodrigues, Universidade Federal de Juiz de Fora




Adegoke, S. A., Braga, J. A. P., Adekile, A. D., & Figueiredo, M. S. (2017). Impact of Hydroxyurea on anthropometry and serum 25-hydroxyvitamin D among children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 40(4), 243–247.

Adegoke, S. A., Figueiredo, M. S., Adekile, A. D., & Braga, A. P. (2017). Comparative study of the growth and nutritional status of Brazilian and Nigerian school-aged children with sickle cell disease. Int Health, 9, 327–334.

Adegoke, S. A., Okeniyi, J. A. O., & Akintunde, A. A. (2016). Electrocardiographic abnormalities and dyslipidaemic syndrome in children with sickle cell anaemia. Cardiovascular Journal of Africa, 27(1), 16–20.

Akinlade, K. S., Adewale, C. O., Rahamon, S. K., Fasola, F. A., Olaniyi, J. A., & Atere, A. D. (2014). Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis. Nigerian Medical Journal, 55(5), 428–431.

Aleluia, M. M., Guarda, C. C., Santiago, R. P., Fonseca, T. C. C., Neves, F. I., Souza, R. Q., Larissa Alves Farias, L. A., Pimenta, F. A., Fiuza, L. M., Pitanga, T. N., Ferreira, J. R. D. Adorno, E. V., Cerqueira, B. A. V., Gonçalves, M. de S. (2017). Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia. Lipids in Health and Disease, 16(74), 1–9.

Alyahya, K. O. (2017). Vitamin D levels in schoolchildren: A cross-sectional study in Kuwait. BMC Pediatrics, 17(1), 1–10.

Barbalho, S. M., Oshiiwa, M., Sato Fontana, L. C., Ribeiro Finalli, E. F., Paiva Filho, M. E., & Machado Spada, A. P. (2017). Metabolic syndrome and atherogenic indices in school children: A worrying panorama in Brazil. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 11(2016), S397–S401.

Baydas, G., Karatas, F., Gursu, M. F., Bozkurt, H. A., Ilhan, N., Yasar, A., & Canatan, H. (2002). Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Archives of Medical Research, 33(3), 276–280.

Behera, S., Dixit, S., Bulliyya, G., & Kar, S. K. (2012). Vitamin a status and hematological values in sickle cell disorder cases. Indian Journal of Medical Sciences, 66(7), 169.

Biswal, S., Rizwan, H., Pal, S., Sabnam, S., Parida, P., & Pal, A. (2018). Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children. Hematology, 24(1), 1–9.

Blaner, W. S., O’Byrne, S. M., Wongsiriroj, N., Kluwe, J., D’Ambrosio, D. M., Jiang, H., Schwabe, R. F., Hillman, E. M. C., Piantedosi, R., Libien, J. (2009). Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage. Biochimica et Biophysica Acta, 1791(6), 467–473.

Brownell, J. N., Schall, J. I., Mcanlis, C. R., Smith-Whitley, K., Norris, C. F., & Stallings, V. A. (2020). Effect of high-dose vitamin A supplementation in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 42(2), 83–91.

Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd ed.) New York: Lawrence Erlbaum Associates.

Dougherty, K. A, Schall, J. I., Kawchak, D. A, Green, M. H., Ohene-frempong, K., Zemel, B. S., & Stallings, V. A. (2012). No improvement in suboptimal vitamin A status with a randomized , double-blind , placebo-controlled trial of vitamin A supplementation in children with sickle cell disease. The American Journal Clinical Nutrition, 96, 932–940.

Ephraim, R. K. D., Adu, P., Ake, E., Agbodzakey, H., Adoba, P., Cudjoe, O., & Agoni, C. (2016). Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis. Journal of Lipids, 2016, 1–5.

Esezobor, C. I., Akintan, P., Akinsulie, A., Temiye, E., & Adeyemo, T. (2016). Wasting and stunting are still prevalent in children with sickle cell anaemia in Lagos , Nigeria. Italian Journal of Pediatrics, 42, 1–8.

Filgueiras, M. D. S., Suhett, L. G., Silva, M. A., Rocha, N. P., & Novaes, J. F. De. (2018). Lower vitamin D intake is associated with low HDL cholesterol and vitamin D insufficiency / deficiency in Brazilian children. 25, 1–9.

García-Morin, M., López-Sangüos, C., Vázquez, P., Alvárez, T., Marañón, R., Huerta, J., & Cela, E. (2016). Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department. Hemoglobin, 40(6), 388–391.

Hassan, M. (2017). ANGPLT3: A novel modulator of lipid metabolism. Global Cardiology Science and Practice, 2017(1), 1–7.

Hochman, B., Nahas, F. X., Oliveira Filho, R. S., Ferreira, L. M. (2005). Desenhos de pesquisa. Acta Cirúrgica Brasileira, 20(Suppl. 2), 2-9.

Institute National Heart Lung and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. (pp. 4–83). (2012).

Jackson, T. C., Krauss, M. J., Debaun, M. R., Strunk, R. C., & Arbeláez, A. M. (2012). Vitamin D deficiency and comorbidities in children with sickle cell anemia. Pediatric Hematology and Oncology, 29(3), 261–266.

Jesus, A. C. S., Konstantyner, T., Lôbo, I. K. V., & Braga, J. A. P. (2018). Socioeconomic and nutritional characteristics of children and adolescents with sickle cell anemia: A systematic review. Revista Paulista de Pediatria, 36(4), 491–499.;2018;36;4;00010

Kazadi, A. L., Ngiyulu, R. M., Gini-Ehungu, J. L., Mbuyi-Muamba, J. M., & Aloni, M. N. (2017). Factors associated with growth retardation in children suffering from sickle cell anemia: First report from central Africa. Anemia, 2017.

Kersten, S. (2017). Angiopoietin-like 3 in lipoprotein metabolism. Nature Reviews Endocrinology, 13(12), 731–739.

Lalanne-Mistrih, M.-L., Connes, P., Lamarre, Y., Lemonne, N., Hardy-Dessources, M.-D., Tarer, V., Etienne-Julan, M., Mougenel, D., Tressières, B., & Romana, M. (2018). Lipid profiles in French West Indies sickle cell disease cohorts, and their general population. Lipids in Health and Disease, 17(1), 38.

Lee, M. T., Licursi, M., & McMahon, D. J. (2015). Vitamin D deficiency and acute vaso-occlusive complications in children with sickle cell disease. Pediatric Blood Cancer, 62, 643–647.

Li, Y., & Teng, C. (2014). Angiopoietin-like proteins 3, 4 and 8: Regulating lipid metabolism and providing new hope for metabolic syndrome. Journal of Drug Targeting, 22(8), 679–687.

Martyres, D. J., Vijenthira, A., Barrowman, N., Harris-Janz, S., Chretien, C., & Klaassen, R. J. (2016). Nutrient insufficiencies/deficiencies in children with sickle cell disease and its association with increased disease severity. Pediatric Blood Cancer, 63(6), 1060–1064.

Mikobi, T. M., Tshilobo, P. L., Aloni, M. N., Akilimali, P. Z., Mvumbi-Lelo, G., & Mbuyi-Muamba, J. M. (2017). Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia : A first report from Central Africa. J Clin Lab Anal, 31(6), 1–6.

Mokondjimobe, É., Longo-Mbenza, B., Ovono-Abessolo, F., Gombet, T., Guie, G., Ngou-Milama, E., & Parra, H. J. (2012). Évaluation du profil lipoprotéique et du risque athérogène chez les drépanocytaires homozygotes et hétérozygotes de Brazzaville. Annales de Biologie Clinique, 70(2), 183–188.

Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M. (2011). HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nature Reviews Cardiology, 8(4), 222–232.

Odetunde, O. I., Chinawa, J. M., Achigbu, K. I., & Achigbu, E.O. (2016). Body Mass Index and other anthropometric variables in children with sickle cell anaemia. Pakistan Journal of Medical Sciences, 32(2), 341–346.

Oztas, Y., Unal, S., Eskandari, G., Tamer, L., & Ozgunes, N. (2018). Vitamin D deficiency and its association with inflammatory markers, lipid profile and regulatory t-cells in pediatric sickle cell disease patients. Indian Journal of Hematology and Blood Transfusion, 34(3), 480–485.

Praharaj, D. L., & Anand, A. C. (2021). Sickle Hepatopathy. Journal of Clinical and Experimental Hepatology, 11(1), 82–96.

Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010). Sickle-cell disease. The Lancet, 376(9757), 2018–2031.

Portney, L.G., &Watkins, M.P. (2007). Foundations of Clinical Research: Applications to Practice. Pearson (3rd ed.). Upper Saddle River, N.J: Pearson/Prentice Hall.

Sabarense, A. P., Lima, G. O., Silva, L. M. L., & Viana, M. B. (2015). Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program. Jornal de Pediatria (Versão Em Português), 91(3), 242–247.

Schall, J. I., Zemel, B. S., Kawchak, D. A., Ohene-Frempong, K., & Stallings, V. A. (2004). Vitamin A status, hospitalizations, and other outcomes in young children with sickle cell disease. Journal of Pediatrics, 145(1), 99–106.

Steinberg, M. H. (2008). Sickle cell anemia, the first molecular disease: Overview of molecular etiology, pathophysiology, and therapeutic approaches. The Scientific World Journal, 8, 1295–1324.

Teixeira, R. S., Arriaga, M. B., Terse-Ramos, R., Ferreira, T. A., Machado, V. R., Rissatto-Lago, M. R., Silveira, P. S., Boa-Sorte, N., Ladeia, A. M. T., & Andrade, B. B. (2019). Higher values of triglycerides:HDL-cholesterol ratio hallmark disease severity in children and adolescents with sickle cell anemia. Brazilian Journal of Medical and Biological Research, 52(10), e8833.

Teixeira, R. S., Terse-Ramos, R., Ferreira, T. A., Machado, V. R., Perdiz, M. I., Lyra, I. M., Nascimento, V. L., Boa-Sorte, N., Andrade, B B., & Ladeia, A. M. (2017). Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia. Plos One, 12(9), 1–14.

Valente-Frossard, T. N. S., Cruz, N. R. C., Ferreira, F. O., Belisário, A. R., Pereira, B. M., Gomides, A. F. F., Resende, G. A. D., Carlos, A. M., Moraes-Souza, H., & Velloso-Rodrigues, C. (2020). Polymorphisms in genes that affect the variation of lipid levels in a Brazilian pediatric population with sickle cell disease : rs662799 APOA5 and rs964184 ZPR1. Blood Cells, Molecules and Diseases, 80(102376).

Vendrame, F., Olops, L., Saad, S. T. O., Costa, F. F., & Fertrin, K. Y. (2019). Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients. Cytokine, 120, 88–91.

Vona, R., Sposi, N. M., Mattia, L., Gambardella, L., Straface, E., & Pietraforte, D. (2021). Sickle cell disease: Role of oxidative stress and antioxidant therapy. Antioxidants, 10(2), 1–27.

Wastnedge, E., Waters, D., Patel, S., Morrison, K., Goh, M. Y., Adeloye, D., & Rudan, I. (2018). The global burden of sickle cell disease in children under five years of age: A systematic review and meta-analysis. Journal of Global Health, 8(2), 1–9.

World Health Organization. (2009). Software for assessing growth of the worlds children and adolescents. In Who Antro Plus for Personal Computers Manual.

Zhang, R. (2016). The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biology, 6(4), 1–11.

Zorca, S., Freeman, L., Hildesheim, M., Allen, D., Remaley, A. T., Taylor, J. G., & Kato, G. J. (2010). Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. British Journal of Haematology, 149(3), 436–445.




How to Cite

CRUZ, N. R. C. .; VALENTE , T. N. S. .; FERREIRA, F. .; MACEDO, L. R. de .; ROCHA, A. S. B. .; NASCIMENTO, D. P. .; GOMIDES, A. de F. .; VALENTE, M. A. .; ALVAREZ-LEITE, J. I. .; VELLOSO-RODRIGUES, C. Lipid profile and nutritional status of a pediatric population with sickle cell anemia: differences between gender and association with severity markers. Research, Society and Development, [S. l.], v. 10, n. 10, p. e344101018934, 2021. DOI: 10.33448/rsd-v10i10.18934. Disponível em: Acesso em: 2 mar. 2024.



Health Sciences